AzTrials
AzTrials

Substance UseNCT04699526

Evaluation of Universal Prevention Curriculum for Schools in Peru

A study testing Universal Prevention Curriculum Training for Schools in people with Substance Use, run by HBSA at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized controlled trial was conducted to evaluate a universal prevention curriculum (UPC) training for Peruvian school administrators and teachers to reduce substance use among students. Twenty-eight schools were randomly assigned to intervention and control conditions (14 per condition). Read more about this study

Who is it for?
Ages 11 to 19 yearsHealthy volunteers can take part
Conditions the study is for
Substance Use
What is being tested?
Universal Prevention Curriculum Training for Schools
Could I receive a placebo?
No, everyone receives an active treatment
How many people
27,012 participants
Where
1 siteUnited States
Study dates
1 May 2018to 30 Nov 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 11 to 19 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Students in participating schools aged 11 to 19

Who cannot join

  • Not attending participating schools

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Prevention Research Center

    Berkeley, California, 94704

Other trials in United States

About this study

This randomized controlled trial was conducted to evaluate a universal prevention curriculum (UPC) training for Peruvian school administrators and teachers to reduce substance use among students. Twenty-eight schools were randomly assigned to intervention and control conditions (14 per condition). Substance use outcomes were assessed with repeated cross-sectional samples of students in 2018 and 2019. Multi-level analyses were conducted to assess intervention effects on students' substance use and related problems.

Read the detailed description

This randomized controlled trial was conducted to evaluate a universal prevention curriculum (UPC) training for Peruvian school administrators and teachers to reduce substance use among students. Twenty-eight schools were randomly assigned to intervention and control conditions (14 per condition). Prevention leadership action teams were formed at intervention schools to implement evidence-based school policies and positive school climate activities, and a classroom substance use prevention curriculum. Substance use outcomes were assessed with repeated cross-sectional samples of students in 2018 and 2019. Multi-level analyses were conducted to assess intervention effects on students' substance use and related problems.

Conditions
Substance Use
Being tested
Universal Prevention Curriculum Training for Schools
Medical subject headings
Substance-Related Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Universal Prevention Curriculum Training for SchoolsOther

    School administrators and teachers participated in UPC training and formed prevention leadership action teams

Study groups in NCT04699526
Study groupRoleWhat they receive
InterventionExperimentalReceived UPC training, school policy and climate interventions, and Unplugged prevention program
Receives: Other: Universal Prevention Curriculum Training for Schools
ControlNo interventionOnly implemented Unplugged prevention program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cigarette smoking

    Smoking cigarettes

    Measured: 1 year

  2. Alcohol use

    Drinking alcoholic beverages

    Measured: 1 year

  3. Heavy drinking

    Five or more consecutive alcoholic drinks

    Measured: 1 year

  4. Marijuana use

    Marijuana use

    Measured: 1 year

  5. Other drug use

    Use of inhalants, cocaine, PCB, hallucinogens

    Measured: 1 year

  6. Problems

    Problems related to substance use

    Measured: 1 year

  7. Friends' substance use

    Friends' use of tobacco, alcohol, marijuana and other drugs

    Measured: 1 year

  8. Awareness of school policies

    Awareness of school tobacco and alcohol policies

    Measured: 1 year

  9. School bonding

    School bonding

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jan 2021
  2. Study start1 May 2018
  3. Primary completion30 Nov 2019
  4. Study completion30 Nov 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
27,012 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04699526
Sponsor's protocol ID
Peru UPC Evaluation
Status last verified
Jan 2021
First submitted
4 Jan 2021
Last updated
7 Jan 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified participant data will be available to other researchers upon request after completion of the current study in December 2022.

Questions about this trial

What is this clinical trial studying?

A study testing Universal Prevention Curriculum Training for Schools in people with Substance Use, run by HBSA at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Jan 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cigarette smoking (time frame: 1 year). The study lists 9 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jan 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in